DSS, INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
DSS$0.45-8.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| For the year ended December 31, 2025 | For the year ended December 31,2024 | |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | $(27,488,000) | $(53,706,000) |
| Adjustments to reconcile net loss to net cash used by operating activities: | ||
| Depreciation and amortization | 2,890,000 | 2,239,000 |
| Issuance of common stock for reward | 870,000 | - |
| Stock based payments for professional services rendered | 190,000 | - |
| Stock based payments to employees and directors | 13,000 | 19,000 |
| (Loss) gain on equity method investment | 16,000 | (1,000) |
| Unrealized loss (gain) on investment in marketable securities | 531,000 | (224,000) |
| Amortization of operating lease ROU assets | 640,000 | 745,000 |
| Write off of inventory | 419,000 | - |
| Provision for inventory obsolescence | (127,000) | - |
| Loss (gain) on sale of real estate assets | 9,622,000 | (14,000) |
| Impairment of fixed assets | - | 264,000 |
| Impairment of investments of investments at cost | - | 782,000 |
| Impairment of real estate | 2,420,000 | 7,288,000 |
| Impairment of intangibles | 600,000 | - |
| Provision for loan losses | 20,000 | 4,398,000 |
| Gain on extinguishment of debt | (595,000) | - |
| Impairment of goodwill | - | 25,093,000 |
| Decrease (increase) in assets: | ||
| Accounts receivable | 558,000 | 1,142,000 |
| Inventory | 152,000 | 377,000 |
| Prepaid expenses and other current assets | 642,000 | 778,000 |
| Investment in trading securities | (316,000) | (3,327,000) |
| Other assets | 91,000 | (65,000) |
| Increase (decrease) in liabilities: | ||
| Accounts payable | (196,000) | (861,000) |
| Accrued expenses | (926,000) | 140,000 |
| ROU liabilities | (614,000) | (686,000) |
| Accrued interest on notes payable | 2,083,000 | 3,648,000 |
| Other liabilities | (624,000) | 3,210,000 |
| Net cash used by operating activities | (9,129,000) | (8,761,000) |
| Cash flows from investing activities: | ||
| Purchase of property, plant and equipment | (268,000) | (133,000) |
| Purchase of real estate | (38,000) | (140,000) |
| Proceeds from sale of real estate | 15,713,000 | - |
| Proceeds from sale of equity investments | - | 3,023,000 |
| Proceeds from disposal of property, plant and equipment | - | 5,609,000 |
| Proceeds from sale of investment, related party | 2,414,000 | - |
| Issuance of new notes receivable, net origination fees | - | (459,000) |
| Payments received on notes receivable | 250,000 | 4,132,000 |
| Payments received on notes receivable, related party | - | 106,000 |
| Net cash provided by investing activities | 18,071,000 | 12,138,000 |
| Cash flows from financing activities: | ||
| Payments of long-term debt | (17,809,000) | (2,626,000) |
| Borrowings of long-term debt, net | 3,250,000 | 876,000 |
| Borrowings of convertible note payable - related party | 500,000 | - |
| Issuances of common stock, net of issuance costs | - | 3,189,000 |
| Net cash provided (used) by financing activities | (14,059,000) | 1,439,000 |
| Net increase (decrease) in cash | (5,117,000) | 4,816,000 |
| Cash and cash equivalents at beginning of year | 11,431,000 | 6,615,000 |
| Cash and cash equivalents and restricted cash at end of period | $6,314,000 | $11,431,000 |
| Cash and cash equivalents | $6,214,000 | $11,431,000 |
| Restricted cash | 100,000 | - |
| Total cash and restricted cash | $6,314,000 | $11,431,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.